FDA NDC Directory · JSON-LD · Markdown

VOYXACT

NDC 59148-400 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namesibeprenlimab
Labeler / ManufacturerOtsuka America Pharmaceutical, Inc.
Marketing categoryBiologic License Application · App BLA761434
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsSIBEPRENLIMAB (200 mg/mL)
Marketing started20251125
Package count1

External sources

Source: openFDA. Public-domain (CC0).